Key regions: Canada, United States, Australia, Brazil, Japan
The Digestives & Intestinal Remedies market in G7 countries has been experiencing steady growth in recent years.
Customer preferences: Customers in G7 countries have shown a growing interest in digestive health and are increasingly seeking remedies to address common digestive issues. Factors such as unhealthy diets, sedentary lifestyles, and high-stress levels have contributed to the rise in digestive problems among the population. As a result, there is a high demand for products that can alleviate symptoms such as bloating, indigestion, and constipation.
Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in G7 countries is the growing popularity of natural and herbal remedies. Customers are becoming more conscious of the ingredients used in the products they consume and are opting for natural alternatives to traditional medications. This trend is driven by a desire for safer and more sustainable options, as well as a preference for holistic approaches to health and wellness.Another trend in the market is the increasing availability and variety of digestive health products. G7 countries have a well-developed healthcare infrastructure, allowing for easy access to a wide range of over-the-counter and prescription digestive remedies. This has led to a competitive market, with companies constantly innovating and introducing new products to meet the diverse needs of customers.
Local special circumstances: Each G7 country has its own unique set of circumstances that influence the Digestives & Intestinal Remedies market. For example, in the United States, the high prevalence of digestive disorders and the presence of a large aging population contribute to the demand for digestive health products. In Japan, where the aging population is also a significant factor, there is a strong focus on probiotic products that promote gut health.
Underlying macroeconomic factors: The growth of the Digestives & Intestinal Remedies market in G7 countries can be attributed to several underlying macroeconomic factors. Firstly, the increasing healthcare expenditure in these countries has resulted in improved access to healthcare services, including digestive health products. Additionally, the growing awareness and understanding of the importance of digestive health have led to a higher demand for related products.Furthermore, the rising disposable incomes in G7 countries have allowed consumers to prioritize their health and wellness, leading to increased spending on digestive remedies. The strong presence of pharmaceutical and healthcare companies in these countries has also contributed to the growth of the market, as they invest in research and development to create innovative products that cater to the specific needs of customers. In conclusion, the Digestives & Intestinal Remedies market in G7 countries is experiencing steady growth due to customer preferences for natural remedies, the availability of a wide range of products, and underlying macroeconomic factors such as increased healthcare expenditure and rising disposable incomes. The market is expected to continue growing as customers prioritize their digestive health and seek effective solutions for common digestive problems.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
